Abiopharma

🔍 Krasner Andrew Jay (Executive)

Company: WILLIS TOWERS WATSON PLC (WTW)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Acquired 4 shares of Restricted Share Unit (Derivative)
  Date: 2026-08-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 758.37 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1

Footnotes:

• F1: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.
• F2: Includes restricted share units credited to the participant's account by the Company pursuant to the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees (the "Plan") accrual formula, net of the units acquired pursuant to the participant's contribution under the Plan.